v3.26.3
Interim Condensed Consolidated Balance Sheets (Parenthetical) - Chemomab Therapeutics Ltd [Member] - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Dec. 31, 2024
Common stock, no par value $ 0 [1] $ 0 [2] $ 0 [2]
Common stock, shares authorized 4,650,000,000 [1] 4,650,000,000 [2] 4,650,000,000 [2]
Common stock, shares issued 579,648,600 [1] 575,381,320 [2] 377,132,220 [2]
Common stock, shares outstanding 579,648,600 [1] 575,381,320 [2] 377,132,220 [2]
Employee and related expenses $ 803 $ 656 [3] $ 934 [3]
Accrued expenses $ 493 337 [4] 1,536 [4]
Related Party [Member]      
Employee and related expenses   458 531
Accrued expenses   $ 74 $ 75
[1] 1 American Depositary Share (ADS) represents 80 Ordinary Shares.
[2] 1 American Depositary Share (ADS) represents 80 Ordinary Shares.
[3] Includes balances due to related parties of $458 thousand and $531 thousand as of December 31, 2025 and 2024, respectively. See Note 12.
[4] Includes balances due to related parties of $74 thousand and $75 thousand as of December 31, 2025 and 2024, respectively. See Note 12.